SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/20 Mimedx Group, Inc. 8-K:7,9 8/10/20 11:137K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 22K 2: EX-99.1 Miscellaneous Exhibit HTML 12K 7: R1 Document and Entity Information HTML 41K 9: XML IDEA XML File -- Filing Summary XML 12K 6: XML XBRL Instance -- d929856d8k_htm XML 12K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- mdxg-20200810_lab XML 47K 5: EX-101.PRE XBRL Presentations -- mdxg-20200810_pre XML 30K 3: EX-101.SCH XBRL Schema -- mdxg-20200810 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 10± 17K 11: ZIP XBRL Zipped Folder -- 0001193125-20-214251-xbrl Zip 11K
Form 8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM i 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): i August 10, 2020
i MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
i Florida | i 001-35887 | i 26-2792552 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
i 1775 West Oak Commons Ct., NE, i Marietta GA i 30062 |
(Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including area code: i (770) i 651-9100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
None | n/a | n/a |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 | Regulation FD Disclosure |
On August 10, 2020, MiMedx Group, Inc. (the “Company” or the “Registrant”) issued a press release announcing the hiring of Robert Stein as Executive Vice President – Research and Development. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit No. |
Description of Exhibit | |
99.1 | Press release dated August 10, 2020. | |
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MIMEDX GROUP, INC. | ||||||
Date: August 10, 2020 | By: | /s/ Peter M. Carlson | ||||
Chief Financial Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 8/10/20 | 3, 4 | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/17/20 Mimedx Group, Inc. S-8 12/17/20 5:422K Donnelley … Solutions/FA |